Vapotherm
Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Learn more
Launch date
Employees
Market cap
AUD20.8m
Enterprise valuation
AUD206m (Public information from Sep 2024)
Share price
$2.17 VAPO
Exeter United States (HQ)
Authorizing premium user...